Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation/NF-κB inhibition
Maha H. Sharawy, Dalia H. El‐Kashef, Ahmed A. Shaaban, Dina S. El‐Agamy
Topics & Concepts
SitagliptinGCLCEndocrinologyInternal medicineFibrosisOxidative stressPharmacologyConcanavalin AMedicineChemistryDiabetes mellitusMetforminBiochemistryDownregulation and upregulationGeneIn vitroChronic Myeloid Leukemia TreatmentsGenomics, phytochemicals, and oxidative stressNF-κB Signaling Pathways